TENX - Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. , a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension.
As of May 15, 2026: spot at $11.77, ATM IV 87.4%, max pain $12.50, net GEX $706.
- Sector
- Healthcare
- Industry
- Biotechnology
- Market Cap
- $204.8M
- Beta
- 1.00
- 52-Week Range
- 5.34-18.38
- CEO
- Christopher T. Giordano
- Employees
- 4
- IPO Date
- Apr 4, 1994
- Exchange
- NASDAQ
What TENX Looks Like to Options Traders Today
positive net gamma exposure ($706) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.214) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The TENX overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked TENX overview questions
- What is TENX?
- TENX is the ticker symbol for Tenax Therapeutics, Inc., a listed security. Tenax Therapeutics, Inc. , a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Listed on NASDAQ. TENX is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the TENX options snapshot look like today?
- As of May 15, 2026, the TENX options snapshot shows spot at $11.77, ATM IV 87.4%, max pain $12.50, net GEX $706, expected move 25.06%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are TENX's key statistics?
- Tenax Therapeutics, Inc. (TENX) carries a market capitalization of $204.8M, beta of 1.00 relative to the broader market, 52-week range of 5.34-18.38. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does TENX belong to?
- Tenax Therapeutics, Inc. operates in the Healthcare sector, in the Biotechnology industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare TENX's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the TENX data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).